STEVEN S CROHN
Medical Practice at Indian Bnd Rd, Scottsdale, AZ
License number
Florida 100605
Issued Date
Dec 18, 2007
Effective Date
Feb 18, 2016
Expiration Date
Jan 31, 2016
Category
Health Care
Type
Medical Doctor
Address
Address
6041 E Indian Bend Rd, Scottsdale, AZ 85253
Phone
(602) 571-1818
Professional information
Apparatus And Method For The Point Treatment Of A Patient By Acupuncture And Light
US Patent:
2007000, Jan 4, 2007
Filed:
Jun 30, 2005
Appl. No.:
11/169371
Inventors:
Steven Crohn - Paradise Valley AZ, US
International Classification:
A61N 5/06
US Classification:
607088000, 128907000
Abstract:
An apparatus for the treatment of a patient at a plurality of treatment points by acupuncture and light treatment. The apparatus includes an enclosure and a source of light within the enclosure. A plurality of flexible conduits for the transmittal of light are provided, each conduit having a first end and a second end. The first end of the conduit is optically connected to the enclosure. A plurality of needles are provided, each needle being suitable for acupuncture and having a first end and a second end having a needle point. The first end of each of the needles is mounted on each of the second ends of the conduits. Each needle is capable of transmitting light therethrough. In use, each needle is implanted into a treatment point of the patient and the light source is activated. Light passes from the light source through the plurality of conduits and needles to the treatment point to simultaneously treat the plurality of treatment points by acupuncture and light.
Implants And Procedures For Promoting Autologous Stem Cell Growth
US Patent:
2014003, Jan 30, 2014
Filed:
Jul 9, 2013
Appl. No.:
13/938199
Inventors:
Steven S. Crohn - Paradise Valley AZ, US
International Classification:
A61F 2/82, A61K 38/19, A61K 31/395, A61K 38/18
US Classification:
424423, 514 81, 424 851, 514 76, 623 142
Abstract:
A biologically engineered stent for treating patients suffering from acute myocardial infarction/ischemia. The stent is inserted in a vessel upstream to and proximal the damaged muscle/ischemic area. The stent elutes Stromal Derived Factor (SDF1)/CXCR4 complex and/or Vascular Endothelial Growth Factor (VEGF) to attract autologous stem cell for the repair of damaged myocardium or tissues and inducing vascularization (creation of collateral vessels) to the ischemic area. The SDF1/CXCR4 acts as a homing mechanism for stem cells. Stem cell mobilizing agents such as Gm-CSF, GCSF and Plerixafor, as a CXCR4 blocker, may be added systemically to assist in stem mobilization. A protocol consisting of multiple doses of Gm-CSF or GCSF may be given in order to mobilize stem cells from the patient. Optionally, stem cells may be injected into the patient. The treatment stimulates repair and improves survival of damaged myocardium and prevents ventricular remodeling.
Composition For Use With Artificial Airway Devices
US Patent:
2007006, Mar 29, 2007
Filed:
Sep 29, 2005
Appl. No.:
11/237541
Inventors:
Steven Crohn - Paradise Valley AZ, US
International Classification:
A62B 7/00
US Classification:
128200240
Abstract:
A composition for applying to an artificial airway device that facilitate lung ventilation, e.g., oropharyngeal masks, and endotracheal tubes, prior to introduction into an air passageway of a patient. The composition includes a) an effective lubricating amount of a safe and effective water based lubricant, b) an effective antibacterial amount of a non-antibiotic biocide for inhibiting the growth of bacteria in the air passageway, preferably xylitol, and c) an effective anti-nausea amount of an anti-nausea composition to inhibit nausea in the patient, preferably peppermint extract.